0001144204-16-076474.txt : 20160121
0001144204-16-076474.hdr.sgml : 20160121
20160121144420
ACCESSION NUMBER: 0001144204-16-076474
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160119
FILED AS OF DATE: 20160121
DATE AS OF CHANGE: 20160121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0000895051
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 581959440
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9620 MEDICAL CENTER DR
STREET 2: STE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-864-2600
MAIL ADDRESS:
STREET 1: 9620 MEDICAL CENTER DR
STREET 2: STE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: ENTREMED INC
DATE OF NAME CHANGE: 19960415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ren Ken
CENTRAL INDEX KEY: 0001490733
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20713
FILM NUMBER: 161353284
MAIL ADDRESS:
STREET 1: 3RD FL, BOROUGH A, BLOCK A
STREET 2: NO. 181 SOUTH TAIBAI ROAD
CITY: XI'AN, SHAANXI PROVINCE
STATE: F4
ZIP: 710065
4
1
v429400_4.xml
OWNERSHIP DOCUMENT
X0306
4
2016-01-19
0
0000895051
CASI Pharmaceuticals, Inc.
CASI
0001490733
Ren Ken
CASI PHARMACEUTICALS, INC.
9620 MEDICAL CENTER DRIVE, SUITE 300
ROCKVILLE
MD
20850
1
1
0
0
CEO and Director
Common Stock
2016-01-19
4
P
0
7537
0.73
A
7537
D
Common Stock
2016-01-19
4
P
0
1100
0.74
A
8637
D
Common Stock
2016-01-19
4
P
0
6063
0.72
A
14700
D
Common Stock
2016-01-19
4
P
0
300
0.71
A
15000
D
/s/ Ken K. Ren, Chief Executive Officer and Director
2016-01-21